Meta Stock Surges After Q4 2025 Earnings Beat and Strong Q1 2026 Revenue Outlook Despite Higher Capex 
NVIDIA, Microsoft, and Amazon Eye Massive OpenAI Investment Amid $100B Funding Push 
Apple Earnings Beat Expectations as iPhone Sales Surge to Four-Year High 
Trump Threatens Aircraft Tariffs as U.S.-Canada Jet Certification Dispute Escalates 
Sandisk Stock Soars After Blowout Earnings and AI-Driven Outlook 
Saks Global to End Saks on Amazon Partnership Amid Bankruptcy Restructuring 
Elon Musk’s SpaceX Explores Merger Options With Tesla or xAI, Reports Say 
CSPC Pharma and AstraZeneca Forge Multibillion-Dollar Partnership to Develop Long-Acting Peptide Drugs 
Federal Judge Signals Possible Dismissal of xAI Lawsuit Against OpenAI 
Toyota Retains Global Auto Sales Crown in 2025 With Record 11.3 Million Vehicles Sold 
American Airlines Plans Return to Venezuela Flights After U.S. Lifts Ban 
Microsoft AI Spending Surge Sparks Investor Jitters Despite Solid Azure Growth 
Panama Supreme Court Voids CK Hutchison Port Concessions, Raising Geopolitical and Trade Concerns 
Tesla Q4 Earnings Beat Expectations as Company Accelerates Shift Toward AI and Robotics 
Chinalco and Rio Tinto Acquire Controlling Stake in Brazil’s CBA for $903 Million 
MIGDAL HA'EMEQ, Israel, May 25, 2017 -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients and medical foods, today announced that Mr. Erez Israeli, the Company’s Chief Executive Officer, will present at the Jefferies 2017 Global Healthcare Conference being held on June 6-9, 2017 at the Grand Hyatt New York in New York City.
Mr. Israeli is scheduled to present on Thursday, June 8, 2017 at 4:30 PM EDT. The presentation will take place in 7 Imperial. The presentation will be followed immediately by a breakout session at 5:00 PM EDT in the Booth Room.
Mr. Israeli and Mr. Oren Bryan, the Company’s Chief Financial Officer, will also be available to participate in one-to-one meetings with investors during the conference.
About Enzymotec Ltd.
Enzymotec is a leading global supplier of specialty lipid-based products and solutions. The Company develops, manufactures and markets innovative bio-active lipid ingredients, as well as final products, based on sophisticated processes and technologies.
Contact The Ruth Group Tram Bui / Alexander Lobo Phone: 646-536-7035 / 7037 [email protected] [email protected]
